A Case of Suspected Drug Interaction Between Topiramate and Co-administered Clarithromycin/Pranlukast

Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2017, Vol 5, Issue 1

Abstract

Case description: A 4-year-old boy presented with tuberous sclerosis and symptomatic partial epilepsy of the upper right extremity. Topiramate was prescribed for the treatment of epilepsy, and seizure behavior was well controlled. However, the patient experienced a significantly increased seizure frequency immediately after the administration of clarithromycin and pranlukast treatment during topiramate treatment. Topiramate is metabolized by CYP3A4, which is inhibited by clarithromycin and pranlukast. Thus, pharmacokinetic interactions may have occurred. This is the first report of a possible drug interaction between topiramate, clarithromycin, and pranlukast.

Authors and Affiliations

Noriaki Hidaka

Keywords

Related Articles

Targeting the Endocannabinoid System for Neuroprotection: A 19F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA

Fatty acid amide hydrolase (FAAH), the enzyme involved in the inactivation of the endocannabinoid anandamide (AEA), is being considered as a therapeutic target for analgesia and neuroprotection. We have developed a brain...

Invitro and Invivo Inhibition of Metyraponemetabolism by Glycyrrhetinic Acid in Male Wistar Rats

Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...

Current Medication Trends and Global Impact on Neurodegenerative Disorders

Neurodegenerative disorders are the medical condition characterized by destruction in neuronal cells, abruption of neuronal activity and distinct involvement of the functional movement. The main neuronal disorders like P...

Another Example of a Successful Use of Computational and Modeling Tools from the Theory of Dynamic Systems in Pharmacokinetic Modeling

The objective of the current more or less theoretical study was to provide another example of a successful use of computational and modeling tools from the theory of dynamic systems in pharmacokinetic modeling. The tools...

An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line

The objective of the current experiment was to evaluate the potential of Consciousness Energy Healing-based test items (Vitamin D3 and DMEM) on bone parameters. Both the TI were distributed into two individual parts. One...

Download PDF file
  • EP ID EP246752
  • DOI 10.13188/2327-204X.1000021
  • Views 108
  • Downloads 0

How To Cite

Noriaki Hidaka (2017). A Case of Suspected Drug Interaction Between Topiramate and Co-administered Clarithromycin/Pranlukast. Journal of Pharmaceutics & Pharmacology, 5(1), 1-2. https://www.europub.co.uk/articles/-A-246752